Answers are grounded in this paper and cite their sources.
ObjectiveTo conduct a systematic review on the efficacy of Defocus Incorporated Multiple Segments (DIMS) spectacle lenses in slowing childhood myopia progression and axial length (AL) elongation, and exploring factors associated with variations in treatment response. MethodsPubMed, EBSCOhost, ProQuest, and ScienceDirect were searched on July 28, 2026 to September 27, 2026. Studies on DIMS spectacle lenses for childhood myopia control were reviewed on spherical equivalent refraction (SER), AL elongation, treatment response predictors, safety and tolerability, visual function, and combination therapies. Findings were synthesized. Results47 studies were included. Most reported that DIMS lenses slowed SER progression and AL elongation compared with single-vision spectacles. Some studies reported that benefits continued long term. Treatment response varied, with age, baseline AL, relative peripheral refraction, and ocular characteristics identified as factors influencing the differences. Available evidence also suggested that DIMS had favorable tolerability and results could be enhanced with combination therapy. ConclusionDIMS spectacle lenses are effective in slowing childhood myopia progression and AL elongation. However, differences in treatment response and limitations in the evidence highlight the need for further studies to clarify predictors of efficacy and establish long term safety.
No takes yet. Share an insight, caveat, or question.
Sarina Vuong (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: